Table 2.
Frequency of ED and treatment for ED
| IIEF-EF ≤25 | Ever received treatment for ED | |||||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Survivors | Siblings | Survivors | Siblings | |||||
| Frequency | (% Yes) | Frequency | (% Yes) | Frequency | (% Yes) | Frequency | (% Yes) | |
| Overall # | 143 / 1166 | (12) | 9 / 213 | (4) | 88 / 1474 | (6) | 6 / 260 | (2) |
|
| ||||||||
| Age at MHQ compleJon †, ‡ | ||||||||
|
| ||||||||
| 20–29 years | 13 / 176 | (7) | 2 / 30 | (7) | 4 / 242 | (2) | 1 / 38 | (3) |
| 30–39 years | 54 / 519 | (10) | 0 / 87 | (0) | 31 / 641 | (5) | 2 / 105 | (2) |
| 40–49 years | 65 / 419 | (16) | 2 / 76 | (3) | 38 / 520 | (7) | 1 / 89 | (1) |
| 50+ years | 11 / 52 | (21) | 5 / 19 | (26) | 15 / 71 | (21) | 2 / 27 | (7) |
|
| ||||||||
| General health (self-reported) †, ‡ | ||||||||
|
| ||||||||
| Excellent | 7 / 200 | (4) | 1 / 49 | (2) | 9 / 234 | (4) | 0 / 54 | (0) |
| Very good | 48 / 522 | (9) | 6 / 91 | (7) | 18 / 632 | (3) | 1 / 107 | (1) |
| Good | 60 / 358 | (17) | 2 / 62 | (3) | 40 / 476 | (8) | 3 / 83 | (4) |
| Fair/poor | 28 / 84 | (33) | 0 / 11 | (0) | 21 / 129 | (16) | 2 / 16 | (13) |
|
| ||||||||
| Met CDC recommendations for physical activity | ||||||||
|
| ||||||||
| Yes | 74 / 597 | (12) | 6 / 126 | (5) | 36 / 736 | (5) | 3 / 150 | (2) |
| No | 66 / 541 | (12) | 3 / 86 | (3) | 52 / 703 | (7) | 3 / 109 | (3) |
|
| ||||||||
| Grade 3+ cardiac condiJon † | ||||||||
|
| ||||||||
| Yes | 15 / 72 | (21) | 1 / 4 | (25) | 10 / 107 | (9) | 0 / 7 | (0) |
| No | 128 / 1094 | (12) | 8 / 209 | (4) | 78 / 1367 | (6) | 6 / 253 | (2) |
|
| ||||||||
| Hypertension requiring medicaJon †, ‡ | ||||||||
|
| ||||||||
| Yes | 26 / 156 | (17) | 3 / 21 | (14) | 19 / 198 | (10) | 1 / 27 | (4) |
| No | 117 / 1010 | (12) | 6 / 192 | (3) | 69 / 1276 | (5) | 5 / 233 | (2) |
|
| ||||||||
| Diabetes †, ‡ | ||||||||
|
| ||||||||
| Yes | 7 / 29 | (24) | 2 / 3 | (67) | 8 / 48 | (17) | 1 / 5 | (20) |
| No | 136 / 1137 | (12) | 7 / 210 | (3) | 80 / 1426 | (6) | 5 / 255 | (2) |
|
| ||||||||
| Depression (self-reported) †, ‡ | ||||||||
|
| ||||||||
| Yes | 36 / 142 | (25) | 2 / 28 | (7) | 29 / 200 | (15) | 2 / 33 | (6) |
| No | 103 / 1004 | (10) | 7 / 183 | (4) | 56 / 1245 | (4) | 4 / 225 | (2) |
|
| ||||||||
| Other major psychiatric illness (self-reported) ^, ‡ | ||||||||
|
| ||||||||
| Yes | 5 / 12 | (42) | 0 / 3 | (0) | 7 / 23 | (30) | 0 / 4 | (0) |
| No | 128 / 1111 | (12) | 9 / 203 | (4) | 74 / 1391 | (5) | 6 / 248 | (2) |
|
| ||||||||
| Prostate disease (self-reported) ‡ | ||||||||
|
| ||||||||
| Yes | 7 / 21 | (33) | 0 / 11 | (0) | 10 / 31 | (32) | 1 / 12 | (8) |
| No | 126 / 1099 | (11) | 9 / 196 | (5) | 72 / 1382 | (5) | 5 / 241 | (2) |
|
| ||||||||
| Currently taking testosterone (self-reported) †, ‡ | ||||||||
|
| ||||||||
| Yes | 19 / 68 | (28) | 0 / 5 | (0) | 14 / 84 | (17) | 2 / 6 | (33) |
| No | 124 / 1092 | (11) | 9 / 207 | (4) | 74 / 1383 | (5) | 4 / 253 | (2) |
Indicates that this factor was significantly associated (p <0.05) with IIEF-EF≤25 overall among all participants. Where numbers permitted, interaction tests were performed to assess whether the association with IIEF-EF≤25 differed for survivor and sibling groups; no statistically significant interactions were found.
Indicates that this factor was significantly associated (p <0.05) with ever having received treatment for ED overall among all participants. Where numbers permitted, interaction tests were performed to assess whether the association with ED treatment differed for survivor and sibling groups; no statistically significant interactions were found.
Rates calculated on total number of participants on whom information was available
Psychiatric illness other than depression or obsessive-compulsive disorder
IIEF-EF = International Index of Erectile Function (Erectile Function Domain); ED = erectile dysfunction